The FY26 Pancreatic Cancer Research Program Translational Research Partnership Award funds collaborative projects among clinicians, population scientists, applied scientists, and basic scientists to move promising pancreatic cancer research toward clinical applications. It requires preliminary data, excludes large-scale clinical trials, and mandates two Principal Investigators with distinct roles submitting coordinated applications.
Open to any type of entity with at least one member having expertise in pancreatic cancer research or patient care. Both initiating and partnering PIs must participate in the application process.
